Literature DB >> 9567251

Maintenance chemotherapy for small cell lung cancer: a critical review of the literature.

J P Sculier1, T Berghmans, C Castaigne, S Luce, C Sotiriou, P Vermylen, M Paesmans.   

Abstract

Maintenance chemotherapy after induction therapy is a controversial topic in small cell lung cancer. We carried out a critical review of the literature on this topic. Since 1980, 13 randomized trials have been published. One shows a statistically significant difference in survival in favor of maintenance, five obtain some survival advantages in subgroups of patients, one shows a significantly shorter survival with maintenance and in six studies, there is no difference between both arms. A quantitative overview or meta-analysis was unpracticable because of the lack of data for calculation of the odds ratio in the publications and because of the heterogeneity of the studies' designs. A qualitative overview was carried out using two scales: the Chalmers scores and the European Lung Cancer Working Party (ELCWP) score. Correlation between both scores was excellent. There was no significant difference in quality scores with both methods between negative trials and those who showed some survival advantage for survival. The overall quality of the publications was not good, with important methodological aspects missing, such as a clear definition of the primary objective or an a priori estimate of the sample size necessary to conduct the trial. We concluded that maintenance chemotherapy could have some indications and that good quality trials, as reflected by very high quality scores, need to be carried out in the future.

Entities:  

Mesh:

Year:  1998        PMID: 9567251     DOI: 10.1016/s0169-5002(97)00084-6

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  13 in total

Review 1.  Small cell lung cancer: past, present, and future.

Authors:  Estelamari Rodriguez; Rogerio C Lilenbaum
Journal:  Curr Oncol Rep       Date:  2010-09       Impact factor: 5.075

Review 2.  Maintenance chemotherapy for advanced non-small-cell lung cancer: new life for an old idea.

Authors:  David E Gerber; Joan H Schiller
Journal:  J Clin Oncol       Date:  2013-02-11       Impact factor: 44.544

3.  Experience with carboplatin and etoposide maintenance chemotherapy in patients with extensive stage small cell lung cancer.

Authors:  Amaan Siddiqi; Huzefa Bahrain; Michael Auerbach
Journal:  Lung Cancer (Auckl)       Date:  2011-08-26

Review 4.  Modern management of small-cell lung cancer.

Authors:  Roberta Ferraldeschi; Sofia Baka; Babita Jyoti; Corinne Faivre-Finn; Nick Thatcher; Paul Lorigan
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 5.  Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis.

Authors:  A P Meert; M Paesmans; T Berghmans; B Martin; C Mascaux; F Vallot; J M Verdebout; J J Lafitte; J P Sculier
Journal:  BMC Cancer       Date:  2001-06-19       Impact factor: 4.430

6.  A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.

Authors:  J P Sculier; M Paesmans; J Lecomte; O Van Cutsem; J J Lafitte; T Berghmans; G Koumakis; M C Florin; J Thiriaux; J Michel; V Giner; M C Berchier; P Mommen; V Ninane; J Klastersky
Journal:  Br J Cancer       Date:  2001-11-16       Impact factor: 7.640

7.  Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation.

Authors:  Kelong Han; Laurent Claret; Alan Sandler; Asha Das; Jin Jin; Rene Bruno
Journal:  BMC Cancer       Date:  2016-07-13       Impact factor: 4.430

8.  Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages.

Authors:  Shuncong Wang; Jianjun Tang; Tiantian Sun; Xiaobin Zheng; Jie Li; Hongliu Sun; Xiuling Zhou; Cuiling Zhou; Hongyu Zhang; Zhibin Cheng; Haiqing Ma; Huanhuan Sun
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

Review 9.  Systematic evaluation of the methodology of randomized controlled trials of anticoagulation in patients with cancer.

Authors:  Gabriel Rada; Holger J Schünemann; Nawman Labedi; Pierre El-Hachem; Victor F Kairouz; Elie A Akl
Journal:  BMC Cancer       Date:  2013-02-14       Impact factor: 4.430

Review 10.  Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis.

Authors:  B Martin; M Paesmans; T Berghmans; F Branle; L Ghisdal; C Mascaux; A-P Meert; E Steels; F Vallot; J-M Verdebout; J-J Lafitte; J-P Sculier
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.